• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Penumbra, Inc. Announces Acquisition of Controlling Interest in MVI Health

Share:

September 16, 2018

Penumbra, Inc., a global healthcare company focused on innovative therapies, today announced it has closed on the acquisition of a controlling interest in its joint venture, MVI Health Inc. After closing the transaction, Penumbra increased its ownership to 90 percent of the equity of MVI Health for $20 million in upfront cash consideration.

MVI Health, originally formed in May 2017, is a joint venture between Penumbra and Sixense Enterprises, a leader in virtual reality software and tracking solutions for enterprise. Since its founding, MVI Health has been developing virtual reality technology for healthcare applications.

MVI Health, headquartered in Alameda, Calif., is supported by investments from Penumbra and licensed intellectual property and other resource contributions from Sixense Enterprises.

Date: September 17, 2018

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: BusinessWire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Hudson Regional Closes on Bayonne Hospital Property; Delivers New Offer to CarePoint To Acquire the OperationsHudson Regional Closes on Bayonne Hospital Property; Delivers New Offer to CarePoint To Acquire the Operations
  • Concert Health Raises $42M to Offer Behavioral Health Services to Primary Care PracticesConcert Health Raises $42M to Offer Behavioral Health Services to Primary Care Practices
  • Oncoshot Partners with Mydoc to Offer Second Opinion Advice for Cancer PatientsOncoshot Partners with Mydoc to Offer Second Opinion Advice for Cancer Patients
  • Public-Private Collaboration Commits to Accelerate Access to Health Services in Africa, Reaching 1.7 Million PeoplePublic-Private Collaboration Commits to Accelerate Access to Health Services in Africa, Reaching 1.7 Million People
  • Satio Partners with BARDA DRIVe to Develop a Novel Patch-Based Ebolavirus DiagnosticSatio Partners with BARDA DRIVe to Develop a Novel Patch-Based Ebolavirus Diagnostic
  • Pear Therapeutics and Remedyone Announce Pharmacy Benefit Manager Coverage for Prescription Digital Therapeutics Reset® & Reset-o® for People with Substance and Opioid Use DisordersPear Therapeutics and Remedyone Announce Pharmacy Benefit Manager Coverage for Prescription Digital Therapeutics Reset® & Reset-o® for People with Substance and Opioid Use Disorders
  • International Myeloma Foundation Partners with Medscape Oncology to Create Professional Education Series on Continuous Treatment in Multiple MyelomaInternational Myeloma Foundation Partners with Medscape Oncology to Create Professional Education Series on Continuous Treatment in Multiple Myeloma
  • Nuvi Acquires Social Healthcare Leader BanyanNuvi Acquires Social Healthcare Leader Banyan

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications